HIF1A and breast cancer: HIF-1α promotes EMT and invasion via activation of the TGF-ß-SMAD3 pathway in breast cancer patients (54), the Wnt/ß-catenin pathway in hepatocellular carcinoma (55) and prostate cancer (56), and hedgehog signaling in pancreatic cancer cells (57).